Navigation Links
Cancer research partnership between UCSF, MMRF to drive drug development
Date:5/29/2009

vering new treatment options to patients, multiple myeloma remains very difficult to treat and effective treatment options are limited," said Wolf. "By bringing to bear the expertise of UCSF in partnership with the MMRF, we are confident that the MMTI will hasten the pace at which new therapies to treat the disease are developed."

UCSF is at the forefront in advancing translational research, which is recognized as the critical weak link in medical science today. It involves moving discoveries made in the lab through the process of animal studies, animal testing and small-scale human trials to determine if a discovery warrants examination on a larger scale by a biotechnology or pharmaceutical company.

Research universities have excelled at discovering the genes and proteins and other cellular and extracellular components that underlie disease processes, but they have not had the infrastructure to investigate the potential of these components as therapeutic targets or tools. The work requires close collaboration between basic researchers, clinical researchers and clinicians.

In 2006, UCSF received a five-year, $100 million grant from the National Institutes of Health to support further development of the UCSF infrastructure for translational medicine. UCSF's existing infrastructure will enable the MMTI to begin its research efforts immediately.

"Currently, there are few translational research initiatives focused solely on multiple myeloma, so we are especially proud to support the MMRF and UCSF, and we are grateful to HHMI for its help in supporting such exciting, important science," said Stephen Grand, an MMRF board member. "The MMTI provides new hope for patients whose treatment options are limited, by enabling the swifter development of new drug candidates and increasing access to promising therapies under investigation."


'/>"/>

Contact: Jennifer OBrien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Small molecule inhibitor shows promise in trastuzumab-resistant metastatic breast cancer
2. Falcon Genomics Awarded Patent for Innovative Cancer Test
3. Cancer cells need normal, nonmutated genes to survive
4. The vulnerable cancer cell
5. New survey highlights growing concern about risk of infection in cancer patients
6. Cancer Survivors Can Still Be Fit, Study Asserts
7. New blood test greatly reduces false-positives in prostate cancer screening
8. Cardiovascular fitness not affected by cancer treatment
9. Cottonseed-based drug shows promise in treating severe brain cancer
10. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
11. Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... TX (PRWEB) March 06, 2015 ... publishing company, created a unique ‘energy’ experiment to ... lives. , After quick ‘5 -7 ... more than 150+ countries reported their life improving ... respondents reported positive results. , According to research, ...
(Date:3/6/2015)... 2015 Dr. Mark Sowell recently returned from ... AZ. Offering programs for advanced education in the field of ... , As a visiting faculty member of this prestigious ... each time he visits Spear Education to participate in a ... “we are training only the top 10% and those willing ...
(Date:3/6/2015)... Alexandria, Virginia (PRWEB) March 06, 2015 ... today it has awarded five-year accreditation status to seven ... Committee mean that another 1.3 million people can now ... to protect and promote the health of their communities. ... protecting and improving the health of people and communities. ...
(Date:3/5/2015)... March 05, 2015 Shania Twain will ... than a decade. She has hinted that this will be ... seeing her perform one last time. She has had a ... beloved country sweetheart has millions of loyal fans around the world. ... native country, Canada, and on June 30th she will be at ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Risperdal ... in a Pennsylvania mass tort litigation currently underway ... a jury has begun hearing testimony in the ... atypical antipsychotic medication can cause gynecomastia, or male ... in question was filed on behalf of a ...
Breaking Medicine News(10 mins):Health News:250,000+ Person ‘Remote Energy’ Event has 94.2% of Respondents saying “Life Got Better” 2Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 3Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3
... journal Addiction , researchers from Bowling Green State ... and substantially elevated risks for illegal drug use in ... incarcerated in the United States has sharply risen over ... to 2,250,000 in 2006. So too has the number ...
... 28, 2010 (Geneva, Switzerland) At the UN Millennium ... world leaders gathered to review progress on the eight ... ill-health by 2015. As the summit came to a ... $40bn to reach the goals, with particular emphasis on ...
... Steven Reinberg HealthDay Reporter , TUESDAY, Sept. ... C-reactive protein (CRP) can vary among different racial and ... heart-disease risk and the value of cholesterol-lowering drugs, a ... of inflammation, and elevated levels have been linked -- ...
... , TUESDAY, Sept. 28 (HealthDay News) -- Think recess, and ... in the school day set aside for running and playing, ... life. What if your workplace started offering recess on the ... good idea but possibly one of the most solid tactics ...
... treatments for the disease or enable earlier diagnosis, say the ... Dentistry. Pancreatic cancer has the lowest survival rate of all ... stages, late diagnosis and its resistance to chemotherapy and radiation ... Research Fund found that nearly three quarters of pancreatic ...
... your ragweed allergies, according to a study from Queen,s University. ... develop ragweed allergy symptoms more quickly than others. But the ... swing, those symptom differences subside. The team, led ... medicine and microbiology & immunology, exposed 123 participants to ragweed, ...
Cached Medicine News:Health News:Father's incarceration associated with elevated risks of marijuana and other illegal drug use 2Health News:International AIDS Society emphasizes universal access to HIV prevention, treatment and care as a prerequisite for improving maternal and child health 2Health News:International AIDS Society emphasizes universal access to HIV prevention, treatment and care as a prerequisite for improving maternal and child health 3Health News:C-Reactive Protein Levels Vary By Race: Study 2Health News:C-Reactive Protein Levels Vary By Race: Study 3Health News:Adding Recess to the Workday Gains Backers 2Health News:Adding Recess to the Workday Gains Backers 3Health News:Adding Recess to the Workday Gains Backers 4Health News:Protein key to growth of pancreatic cancer 2
(Date:3/5/2015)... BAUDETTE, Minn. , March 5, 2015 /PRNewswire/ ... ) today announced that it has acquired the ... Acetate tablets USP 50mg, 100mg and 150mg, previously ... the overall market for this product was approximately ... Arthur S. Przybyl , President and CEO of ...
(Date:3/5/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/4q7gwz/india_pharma ... Pharma Outlook 2015: Accelerating growth to the next level ... report to their offering. Domestic sales ... 2013 caused by the market,s reaction to the new ... continue to be healthy, as the momentum continues and ...
(Date:3/5/2015)... -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), ... that address unmet medical needs in the areas of ... and Chief Executive Officer, Christopher J. Schaber , ... th Annual ROTH Conference in Dana ... at 1:00 PM Pacific Daylight Time (PDT).  The presentation ...
Breaking Medicine Technology:ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 2ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 3India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3
... , ( www.curemark.com ), a drug research and development company ... company has completed its targeted enrollment of Phase III clinical ... Curemark has reached its targeted enrollment for the study of ... Phase III trial at 18 sites across the country. ...
... Health Information Systems has added several experienced health information ... expected to help Prognosis build upon the company,s recent ... market. "We have tapped some of ... It is truly an exciting time for our company ...
Cached Medicine Technology:Curemark Completes Enrollment of Phase III Autism Trials 2Prognosis Health Information Systems Expands Executive Team 2Prognosis Health Information Systems Expands Executive Team 3Prognosis Health Information Systems Expands Executive Team 4
Angled 45 degree shafts 8 mm from tip to bend with 5 mm tying platform. Serrated handle with dull finish. Overall length 3.3 inches....
Ultra-fine 5 mm tying platform is valuable when manipulating delicate 10-0 and 11-0 sutures. Pin in handle keeps tips in alignment. Shafts available straight or angled 45 degrees, 8 mm from tip. Angl...
Curved shafts and tips with 6 mm tying platform. Wide serrated handle with dull finish. Overall length 4.3 inches....
Ultra-fine tying platform with round knurled handle for fingertip rotational control. Curved shafts. Overall length 3.9 inches....
Medicine Products: